OOIR: Observatory of International Research

Papers

(The median citation count of Clinical Microbiology Reviews is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Extracutaneous sporotrichosis	305
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility	265
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections	164
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	160
Transmission of Infections during Cardiopulmonary Resuscitation	151
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance	126
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”	125
Viral infections and pathogenesis of glaucoma: a comprehensive review	122
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases	119
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	102
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus	101
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities	94
Progression of antibiotic resistance in Neisseria meningitidis	87
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options	83
Review of BCG immunotherapy for bladder cancer	82
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics	81
Viral Respiratory Pathogens and Lung Injury	80
Evolutionary Pathways and Trajectories in Antibiotic Resistance	76
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance	71
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control	70
Neisseria gonorrhoeae vaccines: a contemporary overview	69
Congenital Syphilis: a Review of Global Epidemiology	64
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature	59
BCG therapy in bladder cancer and its tumor microenvironment interactions	54
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease	53

Diagnosis, Management, and Future Control of Cholera	53
Aspergillus terreus Species Complex	51
Rapid and accurate testing for urinary tract infection: new clothes for the emperor	50
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	50
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections	48
Trained Immunity as a Preventive Measure for Surgical Site Infections	47
Harnessing the host response for precision infectious disease diagnosis	46
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)	45
Agnostic Sequencing for Detection of Viral Pathogens	45
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome	45
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	44
Artemisinin-resistant malaria	44
Advances in the Microbiology of Stenotrophomonas maltophilia	43
2021 Acknowledgment of CMR Reviewers	40
Editorial Board	40
Editorial Board	39
Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future	39
The challenges of difficult-to-treat Acinetobacter infections	38
COVID-19 therapeutics	37
Pathogenesis of viral infections during pregnancy	37
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing	34
Pneumocystis jirovecii pneumonia in people living with HIV: a review	34
An updated list of eumycetoma causative agents and their differences in grain formation and treatment response	33
Editorial Board	32
Editorial Board	31
SARS-CoV-2 Antiviral Therapy	31
Osteoarticular Mycoses	29
Invasive fusariosis	28
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease	28
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence	28
Natural-Product-Based Solutions for Tropical Infectious Diseases	27
Updated Review onNocardiaSpecies: 2006–2021	27
Laboratory Detection of Malaria Antigens: a Strong Tool for Malaria Research, Diagnosis, and Epidemiology	26
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective	26
Clinical Microbiology Reviews : a 21st century vision	26
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management	26
The endothelium at the interface between tissues and Staphylococcus aureus in the bloodstream	24
Host Immunity and Immunization Strategies for Clostridioides difficile Infection	23
Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use	23
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities	21
Surveillance and prevention of infection in clinical xenotransplantation	21
Masks and respirators for prevention of respiratory infections: a state of the science review	20
Current perspectives in the epidemiology and control of lymphatic filariasis	20
Prion Dissemination through the Environment and Medical Practices: Facts and Risks for Human Health	19
A call for the United States to continue investing in science	19
Advancements and challenges in antifungal therapeutic development	19
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections	17
Human Listeriosis	17
American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis	17
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells	16

2023 Acknowledgment of CMR Reviewers	16
Neurological complications caused by SARS-CoV-2	15
2024 Acknowledgment of CMR Reviewers	14
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies	14
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials	14
Monkeypox Virus Infections in Humans	13
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection	13
Laboratory detection of carbapenemases among Gram-negative organisms	12
The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review	12
Recent advances in therapeutic probiotics: insights from human trials	12
Practical Guidance for Clinical Microbiology Laboratories: Microbiologic diagnosis of implant-associated infections	12
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management	12